Hospital
Carson Tahoe Regional Healthcare
Carson Tahoe Regional Healthcare was paid $23.78M by Medicaid between Jan 2018 and Dec 2024, across 366 billing codes. Its largest line is 99285, emergency room visit (most serious) — 31% of everything it billed.
33Billing provider infoCARSON TAHOE REGIONAL HEALTHCARE
CARSON CITY, NV 89703
CARSON CITY, NV 89703
33aNPI1255360160assigned 07/02/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$23.78M
24GClaims1,193,323
24DCodes billed366
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Nevada
Rank by total paid#10 of 36
Median peer was paid$7.64M
This provider vs. median3.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 169,898 | $3.57M | |
| 2019 | 181,861 | $3.63M | |
| 2020 | 169,852 | $3.00M | |
| 2021 | 187,304 | $3.61M | |
| 2022 | 192,097 | $3.95M | |
| 2023 | 168,643 | $3.43M | |
| 2024incomplete | 123,668 | $2.60M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 31% | 28,909 | 22,432 | $7.30M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 32,493 | 26,719 | $4.85M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.9% | 19,152 | 17,117 | $1.40M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.5% | 21,625 | 20,008 | $839K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.3% | 32,872 | 28,639 | $773K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 3.0% | 1,767 | 1,377 | $720K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.5% | 17,365 | 4,240 | $599K |
| G0378 | Hospital observation service, per hour | 2.5% | 14,363 | 4,652 | $591K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 10,520 | 9,511 | $354K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.4% | 4,561 | 4,312 | $342K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.2% | 8,613 | 7,241 | $294K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.2% | 4,111 | 3,581 | $293K |
354 more codes
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.1% | 727 | $268K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 2,302 | $233K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 1,302 | $223K |
| 59025 | Fetal non-stress test | <1% | 4,243 | $183K |
| 99245 | <1% | 3,060 | $182K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 10,337 | $151K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,810 | $146K |
| 76830 | Ultrasound, transvaginal | <1% | 2,960 | $139K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,788 | $131K |
| 72141 | <1% | 1,184 | $121K | |
| 93971 | <1% | 2,143 | $118K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 9,705 | $110K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,759 | $109K |
| 71250 | <1% | 1,783 | $107K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,634 | $105K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 17,707 | $97K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 3,440 | $96K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13,672 | $93K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 12,342 | $91K |
| 76536 | <1% | 1,288 | $89K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 9,428 | $86K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,977 | $82K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 1,246 | $77K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,240 | $76K |
| 77066 | Tomosynthesis, mammo | <1% | 579 | $73K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 8,315 | $72K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 11,827 | $72K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 496 | $70K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,544 | $62K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 12,105 | $62K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 3,413 | $60K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 24,210 | $60K |
| 80053 | Comprehensive metabolic panel | <1% | 67,436 | $59K |
| 76770 | <1% | 1,419 | $55K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,544 | $55K |
| 97162 | <1% | 2,263 | $53K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 4,926 | $50K |
| 73610 | <1% | 2,343 | $47K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,768 | $47K |
| 86901 | <1% | 4,989 | $44K | |
| 86900 | <1% | 4,189 | $44K | |
| 97597 | <1% | 4,922 | $44K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 7,618 | $43K |
| 86850 | <1% | 3,304 | $38K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,644 | $38K |
| 80061 | Lipid panel | <1% | 10,610 | $37K |
| 73562 | <1% | 2,289 | $36K | |
| 76642 | <1% | 1,476 | $36K | |
| 72100 | <1% | 3,125 | $35K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 2,507 | $35K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,244 | $34K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,052 | $31K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,942 | $30K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 20,469 | $28K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 839 | $25K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 589 | $25K |
| 76801 | <1% | 443 | $25K | |
| 29125 | <1% | 1,094 | $24K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 40 | $24K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 75,083 | $23K |
| 83970 | <1% | 674 | $22K | |
| 87653 | <1% | 1,201 | $21K | |
| 73130 | <1% | 2,424 | $20K | |
| 80050 | General health panel | <1% | 1,062 | $20K |
| 73030 | <1% | 2,528 | $19K | |
| 84481 | <1% | 1,277 | $18K | |
| 0450 | Emergency room services | <1% | 425 | $18K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,228 | $17K |
| 97161 | <1% | 771 | $17K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 32 | $17K |
| 86780 | <1% | 3,099 | $16K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 32 | $16K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,629 | $15K |
| 73110 | <1% | 1,580 | $14K | |
| 73630 | <1% | 2,771 | $13K | |
| 93970 | <1% | 305 | $13K | |
| 83880 | <1% | 2,914 | $12K | |
| 73221 | <1% | 101 | $12K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,371 | $12K |
| 72040 | <1% | 1,159 | $11K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,026 | $11K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,760 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 16,040 | $9K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 217 | $9K |
| 86703 | <1% | 1,509 | $9K | |
| 82677 | <1% | 314 | $9K | |
| 82077 | <1% | 3,993 | $9K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 11,679 | $9K |
| 72110 | <1% | 534 | $8K | |
| 70486 | <1% | 249 | $8K | |
| 71045 | Radiologic examination, chest; single view | <1% | 14,906 | $8K |
| 93976 | <1% | 1,180 | $8K | |
| 82728 | <1% | 2,115 | $8K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,408 | $8K |
| 71271 | <1% | 73 | $8K | |
| 82607 | <1% | 3,588 | $7K | |
| 97163 | <1% | 161 | $7K | |
| 99201 | <1% | 407 | $7K | |
| 95819 | <1% | 34 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,657 | $7K |
| 84153 | <1% | 585 | $7K | |
| 98925 | <1% | 272 | $6K | |
| 70496 | <1% | 239 | $6K | |
| 77080 | <1% | 361 | $6K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 775 | $6K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 173 | $5K |
| 10060 | <1% | 137 | $5K | |
| 87186 | <1% | 5,799 | $5K | |
| 84702 | <1% | 2,963 | $5K | |
| 74018 | <1% | 1,152 | $5K | |
| 77065 | Tomosynthesis, mammo | <1% | 75 | $5K |
| 73564 | <1% | 287 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 94,741 | $5K |
| 70498 | <1% | 261 | $4K | |
| 93458 | <1% | 13 | $4K | |
| 82105 | <1% | 763 | $4K | |
| 72050 | <1% | 295 | $4K | |
| 12001 | <1% | 283 | $4K | |
| 73502 | <1% | 1,171 | $4K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 5,544 | $4K |
| 80329 | <1% | 1,357 | $3K | |
| 93017 | <1% | 2,008 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,593 | $3K |
| 73140 | <1% | 407 | $3K | |
| 84403 | <1% | 204 | $3K | |
| 97166 | <1% | 519 | $3K | |
| 84484 | <1% | 11,180 | $3K | |
| 85610 | <1% | 7,059 | $3K | |
| 80069 | <1% | 1,612 | $3K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 39 | $3K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 972 | $3K |
| 82950 | <1% | 1,688 | $3K | |
| 72146 | <1% | 35 | $3K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 860 | $2K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 1,304 | $2K |
| 00840 | <1% | 154 | $2K | |
| 83690 | <1% | 15,088 | $2K | |
| 64483 | <1% | 14 | $2K | |
| 87807 | <1% | 3,221 | $2K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 52 | $2K |
| 82565 | <1% | 3,903 | $2K | |
| 87088 | <1% | 8,818 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,036 | $2K |
| 86300 | <1% | 159 | $2K | |
| 71101 | <1% | 158 | $2K | |
| 81003 | <1% | 37,373 | $2K | |
| 73090 | <1% | 279 | $2K | |
| 83735 | <1% | 9,362 | $2K | |
| 38204 | <1% | 458 | $2K | |
| 85027 | <1% | 4,810 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,483 | $2K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 4,484 | $1K |
| 94060 | <1% | 26 | $1K | |
| 86038 | <1% | 489 | $1K | |
| 99152 | <1% | 1,948 | $1K | |
| 96376 | <1% | 4,177 | $1K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 15 | $1K |
| 82784 | <1% | 461 | $1K | |
| 81025 | <1% | 7,326 | $1K | |
| 87040 | <1% | 2,124 | $1K | |
| 84480 | <1% | 156 | $1K | |
| 90715 | <1% | 974 | $1K | |
| 86803 | <1% | 1,064 | $1K | |
| 84703 | <1% | 3,089 | $968.26 | |
| 86480 | <1% | 14 | $950.64 | |
| 88342 | <1% | 233 | $934.61 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,055 | $919.21 |
| 99153 | Mod sedat endo service >5yrs | <1% | 694 | $912.67 |
| 82378 | <1% | 48 | $851.21 | |
| 84207 | <1% | 58 | $816.88 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,836 | $804.30 |
| 69209 | <1% | 28 | $802.16 | |
| 73590 | <1% | 308 | $795.90 | |
| 84439 | <1% | 8,702 | $791.06 | |
| 85379 | <1% | 3,807 | $772.17 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 523 | $769.61 |
| 85730 | <1% | 2,252 | $749.00 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 427 | $714.65 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 5,748 | $711.68 |
| 87070 | <1% | 2,201 | $688.01 | |
| 72072 | <1% | 72 | $661.44 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 112 | $654.39 |
| 29515 | <1% | 156 | $619.88 | |
| 36591 | <1% | 27 | $605.36 | |
| 97165 | <1% | 67 | $593.88 | |
| 76870 | <1% | 40 | $593.15 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 402 | $577.46 |
| 86762 | <1% | 1,583 | $576.35 | |
| J3490 | Unclassified drugs | <1% | 1,539 | $566.91 |
| 72070 | <1% | 85 | $550.21 | |
| 29105 | <1% | 113 | $543.83 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,460 | $542.87 |
| 84425 | <1% | 104 | $531.85 | |
| 73560 | <1% | 67 | $508.42 | |
| 87077 | <1% | 2,882 | $496.47 | |
| 29505 | <1% | 122 | $472.47 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,114 | $471.15 |
| 83605 | <1% | 2,032 | $452.60 | |
| 51701 | <1% | 168 | $438.87 | |
| 80306 | <1% | 676 | $421.22 | |
| 86140 | <1% | 3,451 | $399.25 | |
| 84156 | <1% | 2,852 | $366.87 | |
| 87350 | <1% | 947 | $358.94 | |
| 93880 | <1% | 18 | $358.23 | |
| 73080 | <1% | 304 | $348.84 | |
| G0384 | Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 186 | $334.78 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 7,050 | $334.31 |
| 84112 | <1% | 30 | $332.34 | |
| 83516 | <1% | 144 | $332.09 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 1,637 | $327.30 |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 150 | $317.74 |
| 87210 | <1% | 2,306 | $313.46 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 14,811 | $306.85 |
| 87075 | <1% | 573 | $305.92 | |
| 73521 | <1% | 13 | $296.14 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 150 | $289.44 |
| 87340 | <1% | 2,145 | $260.56 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 1,317 | $254.23 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 2,336 | $248.90 |
| 84145 | <1% | 289 | $242.10 | |
| 74019 | <1% | 14 | $240.90 | |
| 85007 | <1% | 3,236 | $227.92 | |
| 85651 | <1% | 3,718 | $224.53 | |
| 82803 | <1% | 410 | $213.44 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 572 | $203.61 |
| 00160 | <1% | 28 | $202.83 | |
| 86364 | <1% | 77 | $200.02 | |
| 82693 | <1% | 438 | $199.17 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 310 | $198.44 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 188 | $198.12 |
| 88304 | <1% | 759 | $195.61 | |
| 82570 | <1% | 2,360 | $194.41 | |
| 82043 | <1% | 1,436 | $167.20 | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | <1% | 87 | $166.31 |
| 97116 | <1% | 98 | $164.04 | |
| 82746 | <1% | 1,274 | $160.63 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,695 | $153.54 |
| 80305 | <1% | 954 | $152.64 | |
| 99001 | <1% | 502 | $152.10 | |
| 84100 | <1% | 1,585 | $138.95 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,322 | $137.58 |
| A9270 | Non-covered item or service | <1% | 19,381 | $127.19 |
| 94729 | <1% | 26 | $125.51 | |
| 82140 | <1% | 112 | $125.02 | |
| 81002 | <1% | 1,467 | $123.35 | |
| 80164 | <1% | 127 | $121.20 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,525 | $119.92 |
| 86677 | <1% | 112 | $117.07 | |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 62 | $116.25 |
| 84146 | <1% | 24 | $112.27 | |
| 87205 | <1% | 697 | $109.40 | |
| 76937 | <1% | 147 | $102.20 | |
| 87493 | <1% | 30 | $97.73 | |
| 29581 | <1% | 37 | $94.62 | |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 17 | $93.21 |
| 73070 | <1% | 34 | $89.96 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 9,851 | $89.57 |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 201 | $88.84 |
| 86200 | <1% | 14 | $87.62 | |
| 88142 | <1% | 29 | $86.28 | |
| 96367 | <1% | 142 | $84.05 | |
| 83550 | <1% | 960 | $81.80 | |
| 82550 | <1% | 791 | $81.15 | |
| 82977 | <1% | 164 | $79.86 | |
| 83540 | <1% | 1,384 | $77.23 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 301 | $76.99 |
| 94726 | <1% | 13 | $75.13 | |
| J2704 | Injection, propofol, 10 mg | <1% | 5,669 | $72.86 |
| 83001 | <1% | 12 | $69.77 | |
| 84550 | <1% | 1,288 | $66.87 | |
| 80076 | <1% | 71 | $62.72 | |
| 86039 | <1% | 28 | $58.61 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 947 | $53.44 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 354 | $53.02 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 228 | $50.70 |
| 85018 | <1% | 403 | $48.93 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 260 | $45.19 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,778 | $41.02 |
| 85014 | <1% | 354 | $39.52 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 899 | $34.42 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 192 | $33.65 |
| 84630 | <1% | 12 | $31.22 | |
| 0250 | <1% | 24 | $30.60 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 389 | $29.56 |
| 82947 | <1% | 460 | $27.33 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 791 | $27.20 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 936 | $26.21 |
| 94760 | <1% | 1,905 | $24.72 | |
| 83615 | <1% | 396 | $24.23 | |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 139 | $20.84 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 931 | $19.59 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 6,319 | $19.37 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 749 | $16.26 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 432 | $15.92 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 150 | $13.54 |
| 80178 | <1% | 17 | $13.53 | |
| 82150 | <1% | 70 | $12.75 | |
| 86999 | <1% | 832 | $8.14 | |
| 86431 | <1% | 60 | $8.01 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 925 | $7.59 |
| 86430 | <1% | 12 | $6.54 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 14,391 | $5.50 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 172 | $0.46 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 167 | $0.19 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 233 | $0.10 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 300 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 37 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 922 | $0.00 |
| 97535 | Self-care/home management training, each 15 minutes | 0% | 174 | $0.00 |
| 96415 | 0% | 55 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 525 | $0.00 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 55 | $0.00 |
| 86592 | 0% | 53 | $0.00 | |
| C1769 | Guide wire | 0% | 196 | $0.00 |
| 87015 | 0% | 41 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 153 | $0.00 |
| 00126 | 0% | 12 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 13 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 17 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 17 | $0.00 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 23 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 0% | 68 | $0.00 |
| 86308 | 0% | 13 | $0.00 | |
| 99000 | 0% | 64 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 0% | 30 | $0.00 |
| 0352U | 0% | 18 | $0.00 | |
| 88307 | 0% | 17 | $0.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 20 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 44 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 132 | $0.00 |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 0% | 26 | $0.00 |
| 77062 | 0% | 49 | $0.00 | |
| 86336 | 0% | 313 | $0.00 | |
| 90837 | Psychotherapy session, about an hour | 0% | 4,223 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 288 | $0.00 |
| 96417 | 0% | 93 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 169 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 106 | $0.00 |
| 93325 | 0% | 14 | $0.00 | |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 0% | 94 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 0% | 17 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 373 | $0.00 |
| 84520 | 0% | 87 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 29 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 107 | $0.00 |
| 96136 | 0% | 33 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 15 | $0.00 |
| J3372 | Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg | 0% | 25 | $0.00 |
| 86753 | 0% | 12 | $0.00 | |
| 82731 | 0% | 16 | $0.00 | |
| 76000 | 0% | 41 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 41 | $0.00 |
| 82540 | 0% | 18 | $0.00 | |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKUCERA, KATIE (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Carson Tahoe Regional Healthcare | Carson City, NV | $791K |
| Carson Tahoe Regional Healthcare | Carson City, NV | $440K |
| Carson Tahoe Regional Healthcare | Carson City, NV | $254K |
| Carson Tahoe Regional Healthcare | Dayton, NV | $191K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.